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Abstract
Introduction. Thyroid paraganglioma is a very rare malig-
nant neuroendocrine tumor. Immunohistochemical features
of thyroid paraganglioma are helpful for the diagnosis. Case
report. A 69-year-old female came to hospital with the
presence of a growing thyroid nodule of the left lobe. Ultra-
sonic neck examination showed 5 cm hypoechoic nodule in
the left thyroid lobe. Thyroid scintigraphy showed a big
cold nodule in the left lobe. Computed tomography (CT)
scan showed left lobe thyroid tumor with tracheal deviation
on the right site. Extended total thyroidectomy was done.
Intraoperative consultation with the pathologist confirmed
thyroid cancer. The pathologist diagnosed thyroid paragan-
glioma on the base of immuohistochemical investigation.
This thyroid paraganglioma was positive for neuron-specific
enolase, chomogranin A, synaptophysin, and S-100 protein
highlighted the sustentacular cells. Tumor cells were nega-
tive for thyroglobulin, epithelial membrane antigen, cyto-
keratin, calcitonin, and carcinoembryonic. After the surgery
the patient was treated with chemotherapy, peptide receptor
radionuclide therapy, and permanent TSH suppressive ther-
apy. The patient was followed with measurements of thy-
roid hormone and serum neuron–specific enolase, chromo-
granin A level, every 6 months. Gastroscopy, colonoscopy,
chest and abdomen CT scan as well as further tests (chest x-
ray, ultrasound of the neck, and whole body octreotide
scintigraphy) were done. No primary neuroendocrine tumor
in digestive sistem or in the chest was found. After more
than 3 years the patient has no evidence of the recurrent
disease. Conclusion. Radical resection of thyroid paragan-
glioma, followed by chemotherapy and peptide receptor ra-
dionuclide therapy, should be considered the treatment of
choice in patients with thyroid gland paraganglioma.
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Apstrakt
Uvod. Tiroidni paragangliom je rijedak maligni neuroendo-
krini tumor. Imunihistohemijske odlike ovog tumora bitne
su za dijagnozu. Prikaz bolesnika. Bolesnica, stara 69 go-
dina, javila se ljekaru zbog progresivno rastuýeg ÿvora u lije-
vom režnju štitaste žlijezde. Ultrazvuÿni nalaz je ukazao na
ÿvor veliÿine 5 cm u lijevom režnju, hipoehogene strukture
sa mikrokalcifikatima. Scintigrafski nalaz ukazao je na hla-
dan ÿvor u lijevom režnju. Kompjuterizovana tomografija
pokazala je tumor lijevog režnja štitaste žlijezde koji je poti-
skivao dušnik u desnu stranu. UraĀena je totalna tireoidek-
tomija. „Intraoperativna konsultacija“ sa patologom ukazala
je na karcinom lijevog režnja štitaste žlijezde. Na osnovu
imunohistohemijskih pretraga preparata, patolog je postavio
dijagnozu tireoidnog paraganglioma. Tumorske ýelije bile su
pozitivne na neuron-specifiÿnu enolazu, hromogranin, si-
naptofizin i S-100 protein, a negativne na tireoglobulin, kal-
citonin, epitelni membranski antigen, citokeratin i karcino-
embriogeni antigen. Nakon hirurškog lijeÿenja sprovedena
je hemioterapija, trajna tireostimulišuýi hormon (TSH) sup-
resivna terapija i protein usmjerena radioterapija. Bolesnica
je kontrolisana svakih 6 mjeseci, uz odreĀivanje nivoa TSH,
serumske neuron specifiÿne enolaze i hromogranina A.
UraĀene su i gastroskopija, pankolonoskopija, kompjuteri-
zovana tomografija grudnog koša i abdomena, scintigrafija
cijelog tijela oktreotidom, i nijedan nalaz nije ukazao na po-
stojanje primarnog neuroendokrinog tumora digestivnog
trakta ili grudnog koša. Nakon više od tri godine kod boles-
nice nema znakova postojanja recidiva bolesti. Zakljuÿak.
Totalna tireoidektomija sa postoperativnom hemioterapijom
i ciljanom peptid-receptor radionuklidnom terapijom jeste
metoda izbora u lijeÿenju bolesnika sa tireoidnim paragan-
gliomom.
Kljuÿne reÿi:
neuroendokrini tumori; tireoidna žlezda;
paragangliom; dijagnoza; hirurgija, operativne
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Introduction
Thyroid paraganglioma is a rare malignant tumor, aris-
ing from the neural crest-derived paraganglia of the auto-
nomic nervous sistem 
1. Extra-adrenal paraganglia which are
histochemically non-chromaffin, are related to the parasym-
pathetic system and are located primarily in the head and
neck region, the superior mediastinum and retroperito-
neum 
2, 3. There are 25-case reports on this tumor described
in the literature 
4. Paragangliomas of the head and neck re-
gion account for 0.012% of all head and neck tumors. They
are malignant in 4–16% cases 
5. The carotid body and glo-
mus jugulare account for more than 80% of the cases. In the
head and neck region, paraganglia are presented as paired
orbital, jugulotympanic, and very rare in the laryngs, trachea
and the thyroid 
6. It is typically presented with fast tumor
growth progression and presented neck tumor. The neuroen-
docrine lesions of the thyroid are few and include C-cells le-
sions (C-cell hyperplasia and medullary carcinoma), mixed
C-cell and follicular-derived tumors, paraganglioma, intra-
thyroid adenoma, and metastasis to the thyroid from neuro-
endocrine carcinoma arising elsewhere.
Thyroid paraganglioma arise from inferior laryngeal
paraganglia, which can be found within the thyroid capsule 
7.
All reported cases of paraganglioma of the thyroid oc-
curred in women, and manifesteted as a solitary nodus, and
ranged in size from 1.5 to 10 cm 
8. They can be confined to
the thyroid or in some cases can exhibit infiltration into sur-
rounding tissue.
Surgical treatment is the basic treatment for thyroid
paraganglioma. Additional treatment includes thyroid
stimulating hormone (TSH) suppressive therapy by L-
thyroxine, chemotherapy, and peptide receptor radionuclide
therapy. Although debates on radicalism of surgical treat-
ment have lasted to this day, total thyroidectomy is the most
widely accepted surgical treatment.
We reported a patient surgically treated for thyroid
paraganglioma.
Case report
A 69-year-old female was sent to the Department for
Endocrine Surgery, Clinical Center of Montenegro due to
neck tumor. Although the patient knew about the nodule in
the left lobe for 1 year, over the last month she noticed pain-
less growth of a nodule. Inspection of the neck showed neck
deformity on the left side, and palpatory 5 cm wide fixed
painless tumor of the left thyroid lobe. There was no evi-
dence of cervical lymph nodes enlargement. Laryngoscopy
showed left laryngeal nerve pulsy. We evaluated a nodule by
fine-needle aspiration (FNA) of the thyroid as follows: THY
5, malignant tumor.
Ultrasonography examination of the neck showed hy-
poechoic heterogeneous 5 cm large and irregular contour
nodule, with calcification in the central part. There was no
enlargement of the cervical lymph nodes. Chest X-ray
showed no metastases. There was a normal thyroid hormone
and calcitonin level. Thyroid scintigraphy showed a cold
nodule in the left lobe. CT scan showed a left thyroid lobe
tumor, 5 cm wide, no tracheal infiltration (Figure 1).
Fig. 1 – Computed tomography scan of thyroid
paraganglioma.
During the surgery a left thyroid lobe tumor was found,
infiltrating strap muscles on the front left neck side. The tu-
mor also infiltrated the left jugular vein and the front part of
the trachea. Extended total thyroidectomy with tangential
tumor resection from trachea was performed (Figure 2).
Fig.  2 – Thyroid paraganglioma – total thyroidectomy.
The entire thyroid gland was removed with the left strap
muscles, left jugular vein. Debulking was very difficult, due
to the presence of a firm neoplasm that spread beyond the
gland capsule with infiltration into surrounding tissues. A
central neck dissection was made and one lymph node with
metastatic disease was found. There was no evidence of
postoperative hypoparathyroidism, or respiratory insuffi-
ciency. The first postoperative day the patient was treated at
Intensive Care Unit, and the following 5 days at the Depart-
ment for Endocrine Surgery. The following day the patient
went home in good condition.
The pathologist diagnosed an invasive neuroendocrine
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formed on formalin-fixed and paraffin-embedded tissue
blocks, 4 micrometer sections were cut, deparaffinized in
xylene and stained with haematoxylin and oesin (H&E).
Light microscopy of this tumor revealed the hallmark nesting
growth pattern with chief and sustentacular cells seen in thy-
roid paraganglioma arrising in sites other than the thyroid
(Figure 3) There were prominent vascularity and thin fibrous
septa separating nests of tumor cells. Some cells also exhib-
ited isolated bizarre cells and mitoses, by examining well-
fixed histological section. In 2 cervical lymphonode we
found metastases of this tumor. This thyroid paraganglioma
was positive for neuron-specific enolase, chromogranin A,
synaptophysin, and S-100 protein highlights the sustentacu-
lar cell (Figure 4). Ki 67 was expressed in 25% of tumor
cells. Tumor cells were negative for thyroglobulin, epithelial
membrane antigen, cytokeratin, calcitonin, and carcinoem-
bryonic antigen (CEA). These immunohistochemical features
of thyroid paraganglioma were helpful for differentiating it
from medullary carcinoma.
Fig. 4 – Tumor cells evident by chromogranin A immu-
nostaining (20 u).
Gastroscopy, colonoscopy, chest and abdomen CT scan
as well as further tests (chest x-ray, ultrasound of the neck,
and whole body octreotide scintigraphy) were done with no
primary neuroendocrine tumor found in the digestive system
or in the chest.
One month after the surgery the wound was healing
well, with no evidence of local recurrence. There was no
evidence of hypoparathyroidism or laryngeal nerve palsy.
The patient continued on L-thyroxin suppressive therapy
with TSH level 0.05 mU/L.
Two months after the surgery the patient had 6 courses
of chemotherapy. One year later, octreoscan body scintigra-
phy showed normal finding, and tumor marker finding with
low chomogranin A serum level. One year after the surgery
the patient had peptide receptor radionuclide therapy. There
was no evidence of local recurrent disease on body octeoscan
scintigraphy.
The patient was regularly controlled for 3 years with no
evidence of local recurrent disease.
Discussion
Medullary carcinoma is a typical neuroendocrine tu-
mor of the thyroid gland. Other neuroendocrine lesions of
the thyroid are C-cell hyperplasia, intrathyroidal nodules
and tumors that display neuroendocrine features including
hyalinizing trabecular neoplasms, insular carcinoma, true
paraganglioma, parathyroid lesions, and tumors metastatic
to the thyroid 
9. All the 25 reported cases of paraganglioma
of the thyroid occurred in women, manifested as a solitary
node
10. They can be confined to the thyroid or some cases
can exhibit infiltration into surrounding tissue. Most thy-
roid paraganglioma are confined within the thyroid capsule,
but in 3 cases the neoplasm was locally invasive and infil-
trated through the tracheal wall 
11. Also, in the presented
case the tumor spread beyond the thyroid capsule with in-
filtration of the left laryngeal recurrent nerve, and strap
muscule. Light microscopy revealed the hallmark nesting
(Zellballen) growth pattern with chief and sustentacular
cells seen in paraganglioma arising in sites other than the
thyroid 
12. Paraganglioma stains positive for chomogranin
A, synaptophysin and S-100 protein. Not surprisingly, the
diagnosis of thyroid paraganglioma is rarely established
preoperatively by FNA biopsy or intraoperatively by frozen
section. The histopathological features usually suggest me-
dullary carcinoma 
13. This is due to the clustering of cells
with granular cytoplasm and a richly vascularized stroma.
In contrast of medullary carcinoma, paraganglioma tends to
exibit S-100 protein staning in sustentacular cells com-
posed at the periphery of the cell nest and they lack stain-
ing for cytokeratin, CEA and calcitonin. Our paragangli-
oma stained positive for neuron-specific enolase, chromo-
granin A, sinaptophysin, and S-100 protein. Differential di-
agnosis includes 2 main entites, namely hyalinizing trab-
ecular adenoma of thyroid and medullary carcinoma 
14.
Tumor cells of medullary carcinoma also can express a va-
riety of other hormons besides calcitonin, such as cortico-
tropin, melatonin-stimulating hormone, serotonin and gas-
Fig. 3 – Cellular detail showing nests of tumor cells
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trin 
15. The gold standard for the diagnosis of medullary
carcinoma is immunostaining for calcitonin 
16. Medullary
carcinoma also stains positive for CEA.
About 6% of patients with thyroid cancer present with
life-threatening tumor invasion of the trachea. After the
complete tumor resection, 5-year and 10-year survival rates
of 40–75% can be achieved 
17. An incomplete tumor resec-
tion has a negative effect on the prognosis. A tangential tu-
mor resection (shaving) is indicated if no transmural invasion
of trachea occurrs.
The aim of enlarged surgical treatment in thyroid carci-
nomas is to guarantee respiratory and alimentary functions as
well as symptomatic benefits, to obtain local control of the
disease and recovery of the adjuvant therapeutic options,
such as metabolic and conventional radiation 
18.
Conclusion
Malignant thyroid paraganglioma is a rare tumor. The
pathologist can diagnose thyroid paraganglioma by examin-
ing well-fixed histological section with immunohistochemi-
cal investigation of chromogranin A, neurone-specific eno-
lase, and protein S-100. Thyroid paraganglioma tumor cells
are negative for thyroglobulin, and calcitonin. This tumor
usually invades the thyroid capsule. Invasive tumor presents
a delicate surgical problem because of radical surgical eradi-
cation. The prognosis of thyroid paragangliloma appears to
be favourable, provided that surgical excision is complete.
Total thyroidectomy, followed by chemotherapy and peptide
related radiotherapy should be considered the treatment of
choice.
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